Louis J. Ignarro

Molecular and Medical Pharmacology University of California, Los Angeles, Los Angeles, CA 
regulation and modulation of nitric oxide (NO) production and cytotoxicity in macrophages, vascular cells, and tumor cells
"Louis J. Ignarro"

The Nobel Prize in Physiology or Medicine 1998 was awarded jointly to Robert F. Furchgott, Louis J. Ignarro and Ferid Murad for their discoveries concerning nitric oxide as a signalling molecule in the cardiovascular system.

Mean distance: 13.9


Sign in to add mentor
Frederick E. Shideman grad student 1966 UMN
 (Catecholamines and the Enzymes Involved in Their Synthesis and Metabolism in the Embryonic and Developing Chick)
Elwood O. Titus post-doc 1966-1968 NIH (NHLBI)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Karlsson JOG, Jynge P, Ignarro LJ. (2023) Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn and Oxaliplatin-Associated Pt. Antioxidants (Basel, Switzerland). 12
Karlsson JOG, Jynge P, Ignarro LJ. (2021) The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOx. Antioxidants (Basel, Switzerland). 10
Ignarro LJ. (2021) Nitric Oxide: A Unique Endogenous Signaling Molecule in Vascular Biology (Nobel Lecture). Angewandte Chemie (International Ed. in English). 38: 1882-1892
Dóka É, Arnér ESJ, Schmidt EE, et al. (2021) Comment on "Evidence that the ProPerDP method is inadequate for protein persulfidation detection due to lack of specificity". Science Advances. 7
Karlsson JOG, Jynge P, Ignarro LJ. (2020) May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients? Antioxidants (Basel, Switzerland). 9
Ignarro LJ. (2020) Inhaled Nitric Oxide and COVID-19. British Journal of Pharmacology
Karlsson JOG, Jynge P, Lundström I, et al. (2019) Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial". Trials. 20: 380
Ignarro LJ. (2019) Nitric oxide is not just blowing in the wind. British Journal of Pharmacology. 176: 131-134
Fukuto JM, Ignarro LJ, Nagy P, et al. (2018) Biological Hydropersulfides and Related Polysulfides: A New Concept and Perspective in Redox Biology. Febs Letters
Karlsson JO, Ignarro LJ, Lundström I, et al. (2015) Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties. Drug Discovery Today. 20: 411-21
See more...